Ximedica
Ximedica is a privately held medical device product development firm providing integrated design, engineering, regulatory, human factors, and contract manufacturing services for medical device, diagnostics, pharma/biotech, and digital health clients from concept through commercialization, now operating as a Veranex subsidiary.
- Company typePrivate
- Founded1991
- HeadquartersProvidence, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Ximedica does
Ximedica is a privately held, fully integrated medical device product development firm headquartered in Providence, Rhode Island. Founded in 1991 by two Rhode Island School of Design industrial designers, the company delivers end-to-end services across six core areas — Medical Technologies, Diagnostics, Digital, Design + Human Factors, Drug Delivery Systems, and Manufacturing — for clients ranging from startups to enterprise MedTech companies. Its technical platform is anchored by FDA-aligned design controls, ISO 13485:2016 certified quality management (including for Class III implantable devices), a 70,000 sq ft ISO Class 7 and Class 8 cleanroom manufacturing facility, dedicated human factors engineering compliant with IEC-62366, and a portfolio of 700+ patents developed across 30+ years of medical device innovation.
The business model combines project-based professional services fees (concept generation, design, engineering, regulatory documentation, human factors) with hardware revenue from contract manufacturing. Distribution is delivered through a direct enterprise sales motion supported by five regional offices (Providence, Philadelphia, Minneapolis, San Francisco, Hong Kong), industry conference participation (AdvaMed, AACC, HIMSS, SAGES, PODD), and thought-leadership content (blog, podcasts, webinars, case studies). Customer segments span medical device manufacturers, diagnostics companies, pharmaceutical/biotech firms developing combination products, and digital health companies. Since 2022, Ximedica has operated as a subsidiary of Veranex, an end-to-end MedTech services platform, with no public revenue disclosure and limited post-2014 funding visibility.
Ximedica firmographics
Firmographics- Name
- Ximedica
- Legal name
- Ximedica LLC
- Website
- https://ximedica.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Ximedica is a privately held medical device product development firm providing integrated design, engineering, regulatory, human factors, and contract manufacturing services for medical device, diagnostics, pharma/biotech, and digital health clients from concept through commercialization, now operating as a Veranex subsidiary.
- Ownership category
- akta.pro rank
Where Ximedica is headquartered
LocationHeadquarters
- HQ city
- Providence
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Ximedica business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Development Services: Project-based medical device design and development services from concept through regulatory submission, including research, prototyping, design controls, and manufacturing transfer.
- Contract Manufacturing: ISO 13485 certified manufacturing of complex medical devices including capital equipment, robotics, and FDA classified products. Services include production planning, quality engineering, process validation, and supply chain management.
- Drug Delivery System Development: Combination product development services for drug delivery systems including regulatory strategy, human factors, and material considerations for pharmaceutical and biotech partners.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Ximedica product offering
Product offeringCore offering
Ximedica is a fully integrated medical device product development firm delivering end-to-end services from research and concept generation through design verification, regulatory submission, manufacturing transfer, and commercial support. The firm operates across six service areas — Medical Technologies, Diagnostics, Digital Health, Design + Human Factors, Drug Delivery Systems, and ISO 13485-certified Manufacturing — serving startups through large medical device companies on a project-based engagement model.
Product overview
Ximedica is a medical device development company offering comprehensive end-to-end product development services from concept to commercialization. The company operates across six integrated service areas: Medical Technologies (surgical robotics, laparoscopic tools, catheter systems, infusion systems, diagnostic devices, and wearable sensors), Diagnostics (in vitro diagnostic platforms, point-of-care systems, and molecular diagnostics), Digital (connected health products, mobile applications, and data strategies), Design + Human Factors (human-centered design and usability engineering), Drug Delivery Systems (combination products, injection systems, and infusion devices), and Manufacturing (ISO-certified clean room assembly and scalable production). Now part of Veranex, Ximedica leverages a vertically integrated process with 30+ years of experience to deliver medical products that are designed, approved, manufactured, and commercially supported.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Technologies Development Design and development services spanning surgical robotics, laparoscopic tools, catheter-based delivery systems, infusion systems, diagnostic devices, wearable sensors, and therapeutic devices for medical device companies.
- Diagnostics Development In vitro diagnostic platform development including point-of-care systems, rapid molecular analysis, laboratory automation, biomarker and drug discovery tools, and microfluidics-based diagnostic instruments for IVD and life science companies.
- Digital Health Development Connected medical device development, mobile health applications, HIPAA-compliant cloud infrastructure, and data strategy services for digital health and connected device companies.
- Design + Human Factors Human-centered design and human factors engineering services including concept generation, usability evaluations, participatory design, IFU design, anthropometric research, and regulatory documentation aligned with FDA guidance and IEC-62366.
- Drug Delivery Systems Development Combination product development services for drug delivery systems including topical, transmucosal, respiratory/inhalation, transdermal, and injection-based delivery, patch pumps, mechanical and electromechanical infusion devices, and blood handling systems for pharmaceutical and biotech partners.
- Medical Device Manufacturing ISO 13485-certified contract manufacturing in a 70,000 sq ft facility with Class 7 and Class 8 cleanrooms, including production planning, quality engineering, process validation, cleanroom assembly and testing, sterilization management, and supply chain management.
- Surgical Robotics Platform Development Specialized surgical robotics platform development services including full-scale robotic platform design, instrument development, and speed-to-market solutions for robotic surgical system developers.
Quantifiable outcome
- Hundreds of satisfied clients in healthcare industry
- +1 more outcomes
Companies that use Ximedica
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Ximedica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Ximedica partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- Red CrowminorPartnership with Red Crow, a digital crowdsourcing and funding platform focused on healthcare innovation. Ximedica offers office hours to RedCrow startups along with other select medtech partners including Experien Group, Alira Health, and Astella.
- Moderna, Inc.coreXimedica announced partnership with Moderna to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of DARPA's Nucleic Acids On-Demand World-Wide (NOW) Program. This represents Ximedica's expertise in rapid manufacturing solutions.
- VeranexcoreXimedica is now part of Veranex, an end-to-end service provider for medical device companies. Veranex provides integrated research, product development, regulatory, and manufacturing services, positioning Ximedica as part of a comprehensive MedTech solutions ecosystem.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Ximedica competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights7 records
Customer concentration
Ximedica social profiles
Digital presenceXimedica compliance and trust
Trust signalCompliance2 records
Ximedica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ximedica leadership team
Management profileNumber of profiles
Profiles1 record
Ximedica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ximedica M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ximedica
What does Ximedica do?
Ximedica is a fully integrated medical device product development firm delivering end-to-end services from research and concept generation through design verification, regulatory submission, manufacturing transfer, and commercial support. The firm operates across six service areas — Medical Technologies, Diagnostics, Digital Health, Design + Human Factors, Drug Delivery Systems, and ISO 13485-certified Manufacturing — serving startups through large medical device companies on a project-based engagement model.
Is Ximedica a public or private company?
Ximedica is a private company. It is classified as corporate owned and is currently operating.
When was Ximedica founded?
Ximedica was founded in 1991. It employs 251 to 500 people.
Where is Ximedica based?
Ximedica is headquartered in Providence, United States, in the North America region.
How does Ximedica make money?
Three revenue lines are on record. Medical Device Development Services are the primary driver. The others are contract Manufacturing and drug Delivery System Development.
Does Ximedica have an API?
No public API is recorded for Ximedica.